Literature DB >> 18378071

CXCR4 and CXCL12 down-regulation: a novel mechanism for the chemoprotection of 3,3'-diindolylmethane for breast and ovarian cancers.

Erin L Hsu1, Natalie Chen, Aya Westbrook, Feng Wang, Ruixue Zhang, Robert T Taylor, Oliver Hankinson.   

Abstract

Cruciferous vegetables are thought to protect against numerous types of cancer. 3,3'-Diindolylmethane (DIM) is an acid-catalyzed product generated during the consumption of cruciferous vegetables and appears to be chemoprotective for breast cancer. The interaction between the chemokine receptor, CXCR4, and its unique ligand, CXCL12, is known to mediate the progression and metastasis of breast and other cancers. Organs to which these cancers metastasize secrete CXCL12, which binds to CXCR4 expressed on the surface of primary cancer cells. This process subsequently stimulates the invasive properties of the cancer cells and attracts them to the preferred organ sites of metastases. We have found that DIM down-regulates both CXCR4 and CXCL12 in MCF-7 and MDA-MB-231 breast cancer cells as well as in BG-1 ovarian cancer cells at the transcriptional level and in an estrogen-independent manner. We demonstrate that the potential of MDA-MB-231 and BG-1 cells for chemotaxis and invasion towards CXCL12, but not towards IL-6 or fetal bovine serum, respectively, is inhibited by DIM. Furthermore, we show that DIM down-regulates CXCR4 under hypoxia and CXCL12 under estradiol-inducing conditions. Our data suggest that one mechanism whereby DIM protects against breast, ovarian, and possibly other cancers is through the repression of CXCR4 and/or CXCL12, thereby lowering the invasive and metastatic potential of these cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378071     DOI: 10.1016/j.canlet.2008.02.033

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants.

Authors:  Massod Rahimi; Kai-Ling Huang; Careen K Tang
Journal:  Cancer Lett       Date:  2010-03-17       Impact factor: 8.679

Review 2.  Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals.

Authors:  Subash C Gupta; Ji Hye Kim; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

3.  Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.

Authors:  Federica Barbieri; Adriana Bajetto; Tullio Florio
Journal:  J Oncol       Date:  2009-12-14       Impact factor: 4.375

4.  Down-regulation of uPA and uPAR by 3,3'-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells.

Authors:  Aamir Ahmad; Dejuan Kong; Zhiwei Wang; Sanila H Sarkar; Sanjeev Banerjee; Fazlul H Sarkar
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

Review 5.  Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.

Authors:  Stephen Safe; Syng-Ook Lee; Un-Ho Jin
Journal:  Toxicol Sci       Date:  2013-06-14       Impact factor: 4.849

Review 6.  Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies.

Authors:  Cynthia A Thomson; Emily Ho; Meghan B Strom
Journal:  Nutr Rev       Date:  2016-05-31       Impact factor: 7.110

7.  3,3'-Diindolylmethane Exhibits Significant Metabolism after Oral Dosing in Humans.

Authors:  Monica L Vermillion Maier; Lisbeth K Siddens; Sandra L Uesugi; Jaewoo Choi; Scott W Leonard; Jamie M Pennington; Susan C Tilton; Jordan N Smith; Emily Ho; H H Sherry Chow; Bach D Nguyen; Siva K Kolluri; David E Williams
Journal:  Drug Metab Dispos       Date:  2021-05-25       Impact factor: 3.579

8.  Modulation of CXCR4, CXCL12, and Tumor Cell Invasion Potential In Vitro by Phytochemicals.

Authors:  Erin L Hsu; Natalie Chen; Aya Westbrook; Feng Wang; Ruixue Zhang; Robert T Taylor; Oliver Hankinson
Journal:  J Oncol       Date:  2009-03-24       Impact factor: 4.375

9.  Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes.

Authors:  Núria Bonifaci; Antoni Berenguer; Javier Díez; Oscar Reina; Ignacio Medina; Joaquín Dopazo; Víctor Moreno; Miguel Angel Pujana
Journal:  BMC Med Genomics       Date:  2008-12-18       Impact factor: 3.063

10.  BreastDefend™ prevents breast-to-lung cancer metastases in an orthotopic animal model of triple-negative human breast cancer.

Authors:  Jiahua Jiang; Anita Thyagarajan-Sahu; Jagadish Loganathan; Isaac Eliaz; Colin Terry; George E Sandusky; Daniel Sliva
Journal:  Oncol Rep       Date:  2012-07-26       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.